Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/10/2023
AmMax and Evopoint Enter into an Exclusive Option Agreement to License...
1/9/2023
NMPA Announces Package Insert Revision of Ibandronate Sodium Inj and T...
1/9/2023
Simnova and Orna Thera Collaborate to Advance Orna's Next Gen Circular...
1/9/2023
Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...
1/6/2023
Top The Chinese Pharma In-licensing Deals in 2022 (PharmCube)
1/6/2023
Top Ten Chinese Biopharma Out-licensing Deals in 2022 (PharmCube)
1/6/2023
CDE Solicits Comments on the Technical Guidelines for R&D of TCM Impro...
1/6/2023
CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M11
1/6/2023
China Issues Two New Policies on BMI Reimbursement of Covid Hospitaliz...
1/6/2023
Recent Executive Moves
1/5/2023
GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...
1/5/2023
CANbridge Consolidates Gene Therapy Portfolio by Exercising License Op...
1/5/2023
NMPA Holds National Drug Regulatory Conference in Beijing
1/5/2023
2022 NRDL Access Negotiation Reinitiated with Industry Hoping for "Mod...
1/5/2023
Aurisco to Build Oligonucleotides Manufacturing Facility in China
1/5/2023
20 Promising New Drugs Anticipated To Be Approved in China 2023 (Pharm...
1/4/2023
NHC and SATCM Announce Action Plan for the Overall Pain Management Tri...
1/3/2023
Fosun Pharma and Henlius Entered into an Exclusive License Agreement f...
12/30/2022
Merck's COVID Drug Molnupiravir Conditionally Approved in China
12/30/2022
Abbott to Exit China's Pediatric Nutrition Market
12/30/2022
Recent Executive Moves
12/30/2022
Financial-related Company News Digest (December 2022)
12/29/2022
NMPA Participates in the CIMDR - GHWP Session & International Drug Reg...
12/29/2022
NMPA Issues the Provisions on Facilitating Main Responsibility of MAHs...
12/28/2022
InnoCare Receives Approval of Tafasitamab in Combo with Lenalidomide f...
12/28/2022
Everest Medicines Begins Operations at mRNA Vaccine Production Site in...
12/27/2022
Antengene and Merck Enter into a Global Clinical Collaboration with M...
12/26/2022
NHSA Announces Comprehensive Inspection of Irregular BMI Coverage Rest...
12/26/2022
Hikma and Junshi Sign Exclusive Licensing Pact for Anticancer Toripali...
12/26/2022
Deloitte: 2023 China LSHC Investment and M&A Market Outlook
Page:
32
/
333
Total number of articles:
9989
:
[First]
[<<]
[30]
[31]
[32]
[33]
[34]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit